1, strong organization, coordination, communication and negotiation ability, strong planning and overall planning;
2. Team leadership, good professional ethics and high sense of responsibility;
3. Treat work affairs positively and operate office system skillfully;
4. Have good project management awareness and excellent management skills, as well as good ability to analyze and solve problems and organizational promotion.
1. The biological development of Kang Hua can be summarized into three stages: the first stage (2004-20 10) and the initial stage of enterprises. The company has completed the preparations from product development to production. The company was founded in 2004. In 2005, R&D center and pilot plant were built and put into use; The production workshop was completed in 2008. The second stage (20 1 1-20 14) is the initial stage of the enterprise. There are two main signs: first, 2012ayw135 meningococcal polysaccharide vaccine passed GMP certification and was officially listed; 2. Freeze-dried rabies vaccine for human use (human diploid cells) 20 13 passed GMP certification. The third stage is the enterprise development stage. On 20 17, the company strategically introduced Tiger Medicine and Pacific Century Capital Investment. From 2065438 to September 2008, the company signed a contract with Wenjiang District Government to establish a vaccine R&D center and production base in Wenjiang Biomedical City [6] to expand the production capacity of vaccine products and develop new vaccine varieties for the company. 20 18, the company completed the shareholding system reform. Corporate culture corporate mission: serving human health core values: innovation, quality, responsibility and integrity.
2. Company Profile Chengdu Kang Hua Biological Products Co., Ltd. (hereinafter referred to as "Kang Hua Bio") was established in 2004 and is located in Chengdu National Economic and Technological Development Zone. The company has international biotechnology experimental center, SPF experimental animal center and GMP production workshop for bacterial and viral vaccines. The existing products of Chengdu Kang Hua Biological Products Co., Ltd. include "ACYW 135 Meningococcal Polysaccharide Vaccine-Maxine" and "Human Diploid Cell Rabies Vaccine (HDCV)". The products have successively won the honorary titles of "Chengdu Independent Innovation Product", "Chengdu Strategic Emerging Product", "Chengdu Key New Product", "Sichuan Famous Brand Product", "Sichuan Key New Product" and "National Key New Product". The company was recognized as "the second place in the human vaccine industry in Sichuan Province" by Sichuan Pharmaceutical Industry Association.
3. The company has been awarded honorary titles such as "Post-doctoral Innovation Practice Base", "Sichuan Honest Enterprise" and "Innovative Enterprise". The company undertook several scientific and technological projects. Enterprise activities are postponed due to the problem of certification materials. In February, the general manager of Chengdu Kang Hua Biological Products Co., Ltd. bribed Yin Hongzhang 50,000 yuan in cash. 2065438+September 2008, Chengdu Kang Hua Biological Products Co., Ltd. applied to entrust Sinopharm Group Pharmaceutical Logistics Co., Ltd. to store and distribute vaccines. In 2009, it was selected as a publicity feature film shooting enterprise of "Development Achievements of Sichuan Pharmaceutical Industry".